Bicara Therapeutics
$18.88
1
+$0.08+0.43% 09:53 Today
Statistics
Day High
19.26
Day Low
18.59
52W High
30.99
52W Low
11.81
Volume
775,255
Avg. Volume
645,015
Mkt Cap
1.24B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
17NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.93
-0.73
-0.53
-0.33
Expected EPS
-0.819231
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-137.95MNet Income
Analyst Ratings
$31.14Average Price Target
The highest estimate is 42.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 57%
Hold 43%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Show more...
CEO
Claire Mazumdar Clemon
Employees
103
Country
United States
ISIN
US0554771032
Listings
0 Comments
Share your thoughts
FAQ
What is Bicara Therapeutics stock price today?▼
The current price of BCAX is $18.88 USD — it has increased by +0.43% in the past 24 hours. Watch Bicara Therapeutics stock price performance more closely on the chart.
What is Bicara Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Bicara Therapeutics stocks are traded under the ticker BCAX.
Is Bicara Therapeutics stock price growing?▼
BCAX stock has fallen by -17.47% compared to the previous week, the month change is a -19.76% fall, over the last year Bicara Therapeutics has showed a +35.54% increase.
What is Bicara Therapeutics market cap?▼
Today Bicara Therapeutics has the market capitalization of 1.24B
When is the next Bicara Therapeutics earnings date?▼
Bicara Therapeutics is going to release the next earnings report on November 17, 2026.
What were Bicara Therapeutics earnings last quarter?▼
BCAX earnings for the last quarter are -0.82 USD per share, whereas the estimation was -0.82 USD resulting in a -0.03% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bicara Therapeutics revenue for the last year?▼
Bicara Therapeutics revenue for the last year amounts to 0 USD.
What is Bicara Therapeutics net income for the last year?▼
BCAX net income for the last year is -137.95M USD.
How many employees does Bicara Therapeutics have?▼
As of September 29, 2026, the company has 103 employees.
In which sector is Bicara Therapeutics located?▼
Bicara Therapeutics operates in the Health & Wellness sector.
When did Bicara Therapeutics complete a stock split?▼
Bicara Therapeutics has not had any recent stock splits.
Where is Bicara Therapeutics headquartered?▼
Bicara Therapeutics is headquartered in BOSTON, United States.